CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease (Q81590992)
Jump to navigation
Jump to search
scientific article published on 24 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease |
scientific article published on 24 October 2006 |
Statements
CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease (English)
Karen Woodson
Keith J O'Reilly
David E Ward
Jack Walter
Jeffrey Hanson
Elyse L Walk
Joseph A Tangrea
24 October 2006